Progression free survival is superior with alemtuzumab vs chlorambucil as front-line therapy for patients with B-cell chronic lymphocytic leukemia

被引：0
|
作者：
Hillmen, P.
Skotnicki, A.
Robak, T.
Jaksic, B.
Sirard, C.
Mayer, J.
机构：
[1] Leeds Gen Infirm, Leeds, W Yorkshire, England
[2] Jagiellonian Univ, Coll Med, Krakow, Poland
[3] Kopernik Mem Hosp, Lodz, Poland
[4] Univ Zagreb, Clin Hosp Merkur, Zagreb, Croatia
[5] GENZYME, Cambridge, MA USA
[6] Univ Hosp Brno, Brno, Czech Republic
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0127
引用
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [41] Comparison the Survival Rate of Fludarabine, Chlorambucil and Cyclophosphamide as First-Line Therapy in Patients with Chronic Lymphocytic Leukemia
    Sedaghat, Sadegh
    Montazeri, Maryam
    Rashidi, Negin
    Montazeri, Mahdi
    Montazeri, Mohammad
    ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2018, 8 (01) : 99 - 104
  • [42] Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy
    Callea, Vincenzo
    Brugiatelli, Maura
    Stelitano, Caterina
    Gentile, Massimo
    Nobile, Francesco
    Morabito, Fortunato
    LEUKEMIA & LYMPHOMA, 2006, 47 (11) : 2314 - 2320
  • [43] PROGRESSION OF A HUMAN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA LINE IN NUDE-MICE
    GHOSE, T
    LEE, CLY
    FAULKNER, G
    LEE, SHS
    FERNANDEZ, LA
    AMERICAN JOURNAL OF HEMATOLOGY, 1988, 28 (03) : 146 - 154
  • [44] Caught in the act: chronic lymphocytic leukemia progression to B-cell prolymphocytic leukemia
    Lanka, S. M.
    Manogna, D.
    Panse, K.
    Saba, Ns
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S123 - S123
  • [45] Alemtuzumab is effective in the treatment of patients with advanced, heavily pretreated B-cell chronic lymphocytic leukemia.
    Fiegl, M
    Hopfinger, G
    Jaeger, G
    Fridrik, M
    Zojer, N
    Walla, B
    Andel, J
    Schmid, FX
    Weisz, H
    Mayer, P
    Buchel, J
    Greil, R
    BLOOD, 2003, 102 (11) : 358B - 358B
  • [46] The B-cell function in patients with chronic lymphocytic leukemia
    Ntsethe, Aviwe
    Nkambule, Bongani
    Dludla, Phiwayinkosi Vusi
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 648 - 648
  • [47] Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients
    Fiegl, Michael
    Falkner, Florian
    Steurer, Michael
    Zojer, Niklas
    Hopfinger, Georg
    Haslbauer, Ferdinand
    Winder, Guntram
    Voskova, Daniela
    Andel, Johannes
    Lang, Alois
    Brychtova, Yvona
    Mayer, Jiri
    Greil, Richard
    Gastl, Guenther
    ANNALS OF HEMATOLOGY, 2011, 90 (09) : 1083 - 1091
  • [48] Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients
    Michael Fiegl
    Florian Falkner
    Michael Steurer
    Niklas Zojer
    Georg Hopfinger
    Ferdinand Haslbauer
    Guntram Winder
    Daniela Voskova
    Johannes Andel
    Alois Lang
    Yvona Brychtova
    Jiri Mayer
    Richard Greil
    Günther Gastl
    Annals of Hematology, 2011, 90 : 1083 - 1091
  • [49] Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia
    Juliusson, G
    Christiansen, I
    Hansen, MM
    Johnson, S
    Kimby, E
    ElmhornRosenborg, A
    Liliemark, J
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (07) : 2160 - 2166
  • [50] Cytogenetic abnormalities and associated efficacy from a phase III study comparing alemtuzumab vs. chlorambucilas first line therapy for B-cell chronic lymphocytic leukemia
    Robak, T.
    Skotnicki, A.
    Dmoszynska, A.
    Hebert, J.
    Wang, Y.
    Belkaci, M.
    Sirard, C.
    Mayer, J.
    Hillmen, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 46 - 46
12345